178 related articles for article (PubMed ID: 35814613)
21. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
23. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
24. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
[TBL] [Abstract][Full Text] [Related]
25. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
26. Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA Delivery and Immune Stimulation for Melanoma Gene Therapy.
Huang J; Wang K; Wu S; Zhang J; Chen X; Lei S; Wu J; Men K; Duan X
Mol Pharm; 2024 Jan; 21(1):267-282. PubMed ID: 38079527
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
Wu J; Li Y; Liu J; Xu Y
J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.
Wang Y; Wang T; Sun Y; Sun W; Wang X
Sci Rep; 2017 Nov; 7(1):15447. PubMed ID: 29133850
[TBL] [Abstract][Full Text] [Related]
29. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
30. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
31. Local and Systemic Delivery of Interleukin-12 Gene by Cationic Micelles for Cancer Immunogene Therapy.
Men K; Huang R; Zhang X; Zhang R; Zhang Y; He M; Tong R; Yang L; Wei Y; Duan X
J Biomed Nanotechnol; 2018 Oct; 14(10):1719-1730. PubMed ID: 30041719
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
33. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
35. Silencing KLF16 inhibits oral squamous cell carcinoma cell proliferation by arresting the cell cycle and inducing apoptosis.
Yang L; Shi YL; Ma Y; Ren WW; Pang GM; Liu J
APMIS; 2022 Jan; 130(1):43-52. PubMed ID: 34779529
[TBL] [Abstract][Full Text] [Related]
36. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
Zhang G; Zhao X; Liu W
Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
[TBL] [Abstract][Full Text] [Related]
37. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
38. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
Zhao Q; Cheng X; Yu W; Bi Y; Guo J; Ma Q; Gong Y; He L; Yu X
Phytomedicine; 2021 Nov; 92():153723. PubMed ID: 34482221
[TBL] [Abstract][Full Text] [Related]
39. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
40. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
